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Abstract
Aims To assess the effect of pregnancy planning on maternal and neonatal outcomes in women with Type 1 diabetes.
Methods Pregnancy planning was assessed retrospectively in a cohort of women who participated in the Diabetes and
Pre-eclampsia Intervention Trial (DAPIT). Pregnancy planning was determined based on self-report as to whether
pregnancy was planned or unplanned. The effect of pregnancy planning on maternal and neonatal outcomes was
examined, controlling for confounding variables.
Results A total of 747 women were included in the study, of whom 39% considered their pregnancy unplanned.
Characteristics associated with unplanned pregnancy included being younger (P<0.001), being a current smoker
(P<0.001), being from a lower social class (P<0.001) and having higher HbA1c values prior to and throughout pregnancy
(P≤0.005). Significantly fewer women with unplanned vs planned pregnancies received pre-pregnancy counselling (24%
vs 64%; P<0.001). Infants of women with unplanned pregnancies were more likely to be small for gestational age (<5th
centile; P=0.004), to be admitted to the neonatal care unit (P=0.001) and to have a longer stay in hospital (P=0.01).
Outcomes did not differ between the groups in relation to pre-eclampsia, congenital malformations or a composite
adverse outcome.
Conclusions Risks associated with diabetes in pregnancy need to be highlighted to all women, their partners and
families, and healthcare professionals. Further research is required to determine if these groups are fully aware of the
risks associated with diabetes in pregnancy.
Diabet. Med. 000, 000–000 (2017)
Introduction
Approximately half of women in the UK describe their
pregnancy as unplanned or are ambivalent towards it [1].
There are a range of behaviours that are known to be
detrimental during pregnancy, including smoking and alco-
hol use [2,3], many of which are associated with pregnancies
that are unplanned. Such behaviours may contribute to the
increased risks associated with unplanned pregnancy [2,4].
Planning a pregnancy is considered particularly important
for women with diabetes, as they are at increased risk of a
number of adverse pregnancy outcomes, including fetal
malformation, stillbirth and pre-eclampsia [5,6]. Poor
glucose control in the preconception period and early
pregnancy has been linked to an increased risk of adverse
outcomes [7].
From adolescence, it is recommended that all women with
diabetes, regardless of pregnancy intention, receive precon-
ception counselling [8]. This is a discussion between women
and their healthcare professionals about the importance of
planning for pregnancy and should informwomen of the need
for pre-pregnancy care prior to conception. Pre-pregnancy
care is specialist care delivered by the multidisciplinary
diabetes care team to help ensure a woman is prepared for
pregnancy, and includes optimization of glycaemic control
[8], the prescription of high-dose folic acid supplements (5
mg) and review of their current medications.
Despite these recommendations, ~60% of women with
diabetes still do not plan their pregnancy [9,10], and enter
pregnancy unprepared, increasing their risk of adverse
outcomes. The Confidential Enquiry into Maternal and
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Child Health (CEMACH) reported an increased risk of poor
pregnancy outcomes in women with unplanned pregnancies
[9]. The effect of pre-pregnancy care on adverse outcomes in
women with diabetes has been studied in some detail.
Evidence shows that attending pre-pregnancy care is associ-
ated with decreased HbA1c levels in early pregnancy and
with a reduced incidence of adverse outcomes, including
congenital malformations, preterm birth and perinatal
mortality [11,12].
The aim of the present study was to assess the effect of
pregnancy planning on maternal and neonatal outcomes in
women with Type 1 diabetes.
Participants and methods
A total of 747 women from the Diabetes and Pre-eclampsia
Intervention Trial (DAPIT) were included. DAPIT was a
multi-centre randomized double-blind placebo-controlled
trial to investigate the use of antioxidants (vitamins C and
E) for the prevention of pre-eclampsia in women with Type 1
diabetes [13]. Pregnancy planning was determined as part of
a patient questionnaire completed by each woman at study
randomization. Women were asked if their pregnancy was
planned, with the response categorized as ‘yes’, ‘no’ or ‘not
known’. Women were also asked if they had received pre-
pregnancy counselling (yes or no option), described to
women as structured advice about the need to maintain
good blood glucose control and healthy lifestyle (with respect
to diet, exercise, BMI, smoking status and alcohol consump-
tion) before trying to become pregnant, including the need to
take folate supplements. This information was not indepen-
dently confirmed or cross-checked against clinical records.
Othermaternal characteristics collected at baseline included
BMI, smoking status, alcohol consumption and social class.
Social class was classified according to occupation of the main
earner in the household, based on the 1990 classifications [14].
Each class was defined by occupation as: I, professional; II,
managerial and technical; IIIN, skilled non-manual; IIIM,
skilled manual; IV, partly skilled; and V, unskilled.
Maternal and neonatal outcomes were collected as part of
DAPIT and included pre-eclampsia, gestational hypertension,
eclampsia, fetal death, fetal malformation, caesarean section
delivery, birth weight, admission to neonatal care unit,
maternal stay in hospital and failure to attend a 6-week
postnatal visit. Pre-eclampsia was defined as gestational
hypertension with proteinuria, in accordance with interna-
tional guidelines [15,16]. Gestational hypertension was
defined as two diastolic blood pressure readings of ≥90
mmHg at least 4 h apart, or one reading of at least 110
mmHg after 20 weeks’ gestation. Proteinuria was defined as
a result of at least 1+ for dipstick analysis of a midstream
specimen on at least two occasions or 300 mg urinary protein
per 24-h period [13]. Late fetal loss was defined as a baby
born dead at a gestational age of 20–23 weeks. Neonatal
death was categorized into early (death within the first 6
complete days of life) and late (death at age 7–27 completed
days of life). Stillbirth was categorized into antepartum (fetal
death occurring before labour at ≥24 weeks’ gestation) and
intrapartum (fetal death occurring during labour at ≥24
weeks’ gestation). Birth weight centile was calculated from
customized birth weight charts [17]. Small for gestational age
(SGA) was defined as birth weight below the 5th centile and
below the 10th centile, while large for gestational age (LGA)
was defined as birth weight above the 90th centile. Informed
written consent was obtained and the West Midlands
Multicentre Ethics Research Committee provided ethical
approval for DAPIT (MREC 02/7/016). DAPIT was carried
out in accordance with the Declaration of Helsinki.
Statistical analysis
Group comparisons were performed using chi-squared and
independent-samples t-tests. Logistic regression analysis was
used to identify outcomes that were associated with
unplanned pregnancies. A number of infrequent outcomes
were combined a priori to create a composite adverse
outcome: miscarriage; late fetal loss; stillbirth; neonatal
death; termination; and major fetal malformation. All out-
comes were adjusted for smoking, social class, maternal age,
BMI, parity and centre. All statistical analyses were performed
using SPSS version 20 (IBM Corp, Armonk, NY, USA).
Results
Characteristics
The maternal characteristics of women with planned and
unplanned pregnancy are summarized in Table 1. Of the 747
women included in the study, 455 (60.9%) described their
pregnancy as planned and 292 (39.1%) as unplanned.
Women who reported having an unplanned pregnancy were
significantly younger and more likely to smoke compared
with women who had a planned pregnancy (P<0.001).
Women with unplanned pregnancies tended to be in a lower
social class (P<0.001) and to book later at their first
antenatal visit than those who planned their pregnancy
What’s new?
• Being young, a smoker and from a lower social class
were associated with unplanned pregnancy.
• Outcomes that were associated with unplanned preg-
nancy were very low birth weight and greater neonatal
and maternal care requirements post-delivery
• Poor preconception counselling rates among women
who did not plan pregnancy suggests an urgent need for
strategies to ensure all women receive preconception
counselling, regardless of pregnancy intention.
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(P=0.01). Women with planned pregnancies were signifi-
cantly more likely to have received pre-pregnancy coun-
selling than women with unplanned pregnancies (P<0.001).
Those with unplanned pregnancies had significantly higher
HbA1c values 6 months prior to and throughout pregnancy,
compared with those with planned pregnancies (P≤0.005). A
significantly higher proportion of women who planned their
pregnancy were taking folic acid prior to conception than
those who did not plan pregnancy (P<0.001).
Maternal and neonatal outcomes
Maternal and neonatal outcomes are reported in Table 2.
Gestational age at delivery was significantly lower in women
with unplanned vs planned pregnancies (P=0.02).
Rates of pre-eclampsia and gestational hypertension did
not differ significantly between the two groups. There were
no significant differences between planned and unplanned
pregnancies with regard to type of delivery, with similar
proportions having vaginal and caesarean section
deliveries.
There was a significant difference in birth weight between
planned and unplanned pregnancies (P=0.008). This differ-
ence persisted after correction for gestational age; infants of
women with unplanned pregnancies were more likely to be
SGA, whether defined by the 5th centile (P=0.001) or the 10th
centile (P=0.01). After adjusting for other covariates, SGA
defined by the 10th centile was no longer significant (P=0.10),
but remained significant for SGA defined by the 5th centile
(P=0.004).
Table 1 Maternal characteristics of women with planned and unplanned pregnancies
Characteristic
Planned pregnancy Unplanned pregnancy
Pnmax=455 nmax=292
Age, years 30.9 (4.8) 27.6 (6.3) <0.001
Gestational age at first antenatal visit, weeks 8.6 (2.7) 9.1 (2.9) 0.01
BMI, kg/m2 27.5 (4.6) 27.4 (4.7) 0.80
Woman’s ethnic origin non-white, n (%) 13 (3) 10 (3) 0.66
Marital status, n (%)
Married 366 (74) 104 (36)
Cohabiting 96 (21) 90 (31) <0.001
Never married 15 (3) 85 (29)
Social class, n (%)
Professional/managerial and technical occupations (I,II) 222 (49) 79 (27)
Skilled, partly-skilled and unskilled occupations (III,IV,V) 202 (46) 160 (55) <0.001
Not known/not classified 31 (7) 53 (18)
≤12 years in education, n (%) 155 (34) 135 (47) <0.001
Duration of diabetes, years 14.8 (8.2) 14.1 (8.2) 0.25
Current smoker, n (%) 67 (15) 78 (27) <0.001
Alcohol use, n (%)
Never/stopped before pregnancy 255 (56) 154 (53)
Stopped during pregnancy 150 (33) 150 (36) 0.66
Current 50 (11) 32 (11)
Primiparous, n (%) 215 (47) 154 (53) 0.14
Abnormal renal status before this pregnancy*, n (%) 22 (5) 19 (7) 0.31
Retinal status before this pregnancy, n (%)
Normal 322 (72) 210 (74)
Background retinopathy 84 (19) 55 (19) 0.60
Abnormal** 39 (9) 19 (7)
Recall receiving pre-pregnancy counselling, n (%) 292 (64) 70 (24) <0.001
HbA1c, mmol/mol
Pre-pregnancy (≤6 months prior) 61 (16) 74 (21) <0.001
Randomisation (8–22 weeks’ gestation) 52 (12) 59 (12) <0.001
34 weeks’ gestation 48 (7) 50 (8) 0.005
HbA1c, %
Pre-pregnancy (≤6 months prior) 7.7 (1.5) 8.9 (1.9)
Randomisation (8–22 weeks’ gestation) 7.0 (0.8) 7.5 (1.1)
34 weeks’ gestation 6.5 (0.6) 6.7 (0.8)
Proportion with HbA1c ≤50 mmol/mol, n (%)
Pre-pregnancy (≤6 months prior) 88 (25) 18 (9) <0.001
Randomization (8–22 weeks’ gestation) 165 (41) 67 (27) <0.001
34 weeks’ gestation 225 (69) 105 (58) 0.01
Systolic blood pressure at randomisation (8–22 weeks’ gestation), mmHg 119.2 (11.9) 118.4 (12.0) 0.35
Diastolic blood pressure at randomization (8–22 weeks’ gestation), mmHg 75.1 (8.4) 73.9 (8.7) 0.05
Taking folic acid prior to conception, n (%) 325 (72) 29 (10) <0.001
Data are mean (SD) unless otherwise stated.
*Includes microalbuminuria, macroalbuminuria and 24h urinary protein >3 g/24 h.
**Includes proliferative retinopathy, maculopathy, previous vitrectomy and blindness.
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Rates of major congenital malformations and adverse
outcomes did not differ significantly between the groups.
Infants of women with unplanned pregnancies were signifi-
cantly more likely to be admitted to a neonatal intensive care
unit (P<0.001), a finding which remained significant after
adjustment for covariates. A significantly higher proportion of
infants from unplanned compared with planned pregnancies
remained in hospital for > 10 days; P=0.006). This difference
also remained significant after adjustment for covariates.
Discussion
The majority of research to date has focused on the
association of pre-pregnancy care with pregnancy outcomes
in women with diabetes, with only a small number of studies
investigating pregnancy planning [18,19]. The present study
showed that almost 40% of women with Type 1 diabetes did
not plan their pregnancy, with only a quarter of women
reporting having received preconception counselling.
Younger women and those of lower social class were
significantly less likely to plan their pregnancies. Unplanned
pregnancy was associated with higher HbA1c levels prior to
and throughout pregnancy, lower folic acid uptake, more
smoking in pregnancy and higher rates of SGA infants, infant
neonatal intensive care unit admission and neonatal hospital
stay exceeding 10 days. Previous studies in the general
population have similarly found that women with an
unplanned pregnancy were more likely to be younger,
classed as socially deprived, and to engage in detrimental
behaviours, including smoking [1,2,20], and were also more
likely to have adverse outcomes [18].
With regard to HbA1c levels in pregnancy, evidence has
shown that higher levels are associated with a number of
adverse outcomes, including congenital malformations,
macrosomia and pre-eclampsia [21,22]. In the present study,
although women with unplanned pregnancies had signifi-
cantly higher HbA1c levels before and throughout their
pregnancies, rates of outcomes such as those mentioned,
were not significantly higher when compared to women with
planned pregnancies. Smoking has previously been shown to
reduce the risk of pre-eclampsia [23] and also to increase the
risk of SGA infants [24], and so may explain similar rates of
pre-eclampsia and LGA infants in the present study. The
adjustment for smoking status in our logistic regressions,
however, did not suggest that it had much of a confounding
effect.
The proportion of women who reported receiving pre-
pregnancy counselling was significantly lower among those
with unplanned pregnancies. It is important that all women
with diabetes receive advice about pregnancy planning, with
previous evidence showing a reduction in adverse outcomes
associated with pre-pregnancy care [11]; however, it is
interesting to note the similar rates of alcohol consumption
between the two groups, and that a small proportion of
women with unplanned pregnancies were taking folic acid
prior to pregnancy, which may demonstrate that some
messages are getting through. Those who attend pre-
pregnancy counselling/care are a self-selecting group, so
other more pragmatic solutions may be needed. These may
include education about relationships and safe sex, and
access to safe, effective contraception, particularly for
women of lower social class.
It is unclear why women in the present study did not plan
their pregnancies, but previous research suggests that both
women and healthcare professionals are not aware of the full
range of risks and complications associated with diabetes in
Table 2 Maternal and fetal outcomes of women with planned and unplanned pregnancies
Outcome
Planned pregnancy
(n=455)
Unplanned pregnancy
(n=292)
Odds ratio (95%CI) for unplanned vs
planned
n/N (%) n/N (%) Unadjusted Adjusted†
Pre-eclampsia 74/448 (17) 49/286 (17) 1.05 (0.70, 1.55) 1.23 (0.77, 1.95)
Gestational hypertension 53/448 (12) 30/286 (11) 0.87 (0.54, 1.40) 0.76 (0.45, 1.30)
Eclampsia 0/447 (0) 3/286 (1) – –
Caesarean delivery 307/454 (68) 200/286 (69) 1.04 (0.76, 1.43) 1.38 (0.96, 1.98)
Foetal death 12/449 (3) 6/284 (2) 0.79 (0.29, 2.12) 0.70 (0.24, 2.05)
SGA <5th centile 13/446 (3) 24/284 (9) 3.08 (1.54, 6.14)** 3.10 (1.42, 6.75)**
SGA <10th centile 26/446 (6) 31/284 (11) 1.98 (1.15, 3.41)* 1.68 (0.91, 3.11)
LGA >90th centile 230/446 (52) 149/284 (53) 1.04 (0.77, 1.40) 1.19 (0.84, 1.68)
Major fetal malformation 15/454 (3) 13/291 (5) 1.37 (0.64, 2.92) 0.96 (0.41, 2.24)
Adverse outcome¶ 30/455 (7) 26/292 (9) 1.39 (0.80, 2.39) 1.06 (0.57, 1.95)
Admission to neonatal intensive care
unit
218/436 (50) 178/277 (64) 1.80 (1.32, 2.45)** 1.84 (1.28, 2.66)**
Infant stayed >10 days in hospital 65/434 (15) 64/277 (23) 1.71 (1.16, 2.51)** 1.75 (1.13, 2.70)*
Did not attend 6-week postnatal visit 34/436 (12) 27/275 (15) 1.35 (0.88, 2.07) 1.15 (0.69, 1.93)
SGA, small for gestational age; LGA, large for gestational age.
†Odds ratio (95% CI) from logistic regression adjusted for smoking, social class, maternal age, BMI, parity and centre.
*P<0.05, **P<0.01.
¶Includes miscarriage, late fetal loss, stillbirth, neonatal deaths, termination and major malformation.
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pregnancy [10,25,26]. It is important that pregnancy plan-
ning is seen as a shared responsibility among women, their
partners, their families and their healthcare providers.
Further research is needed to determine the extent to which
these groups are aware of the risks and complications
associated with diabetes in pregnancy.
The present study has a number of strengths. Firstly,
DAPIT includes one of the largest contemporary datasets of
women with Type 1 diabetes, with 762 women from across
the UK. The study comprises a well characterized cohort of
women with Type 1 diabetes, with extensive information
being collected about pregnancy and pregnancy outcomes.
Secondly, the study protocol included details of an extensive
number of maternal and neonatal outcomes in these
women.
The study also has a number of limitations. Participants in
the study were those who consented to take part and, as a
result, they may not be truly representative of the total
population of women with diabetes. Pregnancy planning was
a self-reported response and not all participants may have
answered honestly, which could have led to a bias towards
under-reporting of unplanned pregnancies. Additionally, it is
possible that women biased their answers in relation to other
questions, such as questions surrounding the use of alcohol in
pregnancy. The study was also unable to determine if women
specifically received specialized pre-pregnancy care or pre-
pregnancy counselling as it was not possible to relate the data
back to pre-pregnancy care clinics. It is therefore likely that
those who reported having received preconception coun-
selling represent a mixture of women who received coun-
selling and specialized pre-pregnancy care.
In conclusion, although pregnancy planning did not affect
the rates of all maternal and neonatal outcomes, unplanned
pregnancy was associated with higher rates of SGA infants,
admission to a neonatal intensive care unit and a longer
neonatal stay in hospital. This study showed an association
between lower social class and unplanned pregnancy in
women with Type 1 diabetes. It is important that the risks
associated with diabetes in pregnancy are highlighted to all
women, their partners and families, and also to healthcare
professionals. In addition to this, women, particularly those
from lower social classes, should have access to good sex
education and safe effective contraception, which may go
some way to reducing unplanned pregnancies. Further
research is required to determine the awareness among both
women with diabetes and their healthcare professionals of
the risks associated with diabetes in pregnancy.
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